LEMIF yields 970.50% · MRK yields 2.81%● Live data
📍 LEMIF pulled ahead of the other in Year 1
Combined, LEMIF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LEMIF + MRK for your $10,000?
Leading Edge Materials Corp. explores for and develops a portfolio of raw material projects in Europe. The company primarily explores for graphite, lithium, nickel, cobalt, and rare earth elements. It holds a 100% interest in the Woxna graphite project that includes four concessions consisting of Kringelgruven, Mattsmyra, Gropabo, and Mansberg located in Gavleborg County, central Sweden. The company also holds interests in the Norra Karr HREE project located in south-central Sweden; and a 51% interest in the Bihor Sud nickel cobalt exploration alliance located in Romania. Leading Edge Materials Corp. was formerly known as Flinders Resources Limited and changed its name to Leading Edge Materials Corp. in August 2016. The company is headquartered in Vancouver, Canada.
Full LEMIF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.